Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Experimental Eye Research|October 11, 2020
Corneal development: Role of the periocular mesenchyme and bi-directional signalingHaydn Walker, Monica Akula, Judith A West-MaysJournal of Neuroscience Research|April 17, 2018
Relationship between neural crest cell specification and rare ocular diseasesMonica Akula, Jeong Won Park, Judith A West-MaysBioengineering (Basel, Switzerland)|February 23, 2024
Seeing the Future: A Review of Ocular TherapyMaiya Whalen, Monica Akula, Shannon M McNamee, et al.Bioengineering (Basel, Switzerland)|January 22, 2024
Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and TreatmentsKaden L Nystuen, Shannon M McNamee, Monica Akula, et al.Experimental Eye Research|May 1, 2020
AP-2β is required for formation of the murine trabecular meshwork and Schlemm's canalMonica Akula, Aftab Taiyab, Paula Deschamps, et al.Current Eye Research|March 10, 2021
Progressive Loss of Retinal Ganglion Cells in Activating Protein-2β Neural Crest Cell Knockout MiceAftab Taiyab, Anthony Saraco, Monica Akula, et al.Journal of Neuroscience Research|November 25, 2021
Deletion of transcription factor AP-2β from the developing murine trabecular meshwork region leads to progressive glaucomatous changesAftab Taiyab, Monica Akula, Japnit Dham, et al.Disease Models & Mechanisms|August 3, 2016
Conditional deletion of AP-2β in mouse cranial neural crest results in anterior segment dysgenesis and early-onset glaucomaVanessa B Martino, Thomas Sabljic, Paula Deschamps, et al.Scientific Reports|July 17, 2024
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degenerationShannon M McNamee, Monica Akula, Zoe Love, et al.Gene Therapy|January 25, 2024
Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model Rho<sup>P23H+/</sup><sup></sup>Shannon M McNamee, Natalie P Chan, Monica Akula, et al.Pageof 1